1.Lencz, T, Cornblatt, B, Bilder, RM. Neurodevelopmental models of schizophrenia: Pathophysiologic synthesis and directions for intervention research. Psychopharm Bull. 2001;35.
2.Cornblatt, B, Obuchowski, M, Roberts, S, Pollack, S, Erlenmeyer-Kimling, L. Cognitive and behavioral precursors of schizophrenia. Developmental Psychopathology. 1999;11:487–508.
3.Siever, LJ, Silverman, JM, Horvath, TBet al.Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Arch Gen Psychiatry. 1990;47:634–640.
4.Kendler, KS, McGuire, M, Gruenberg, AM, Walsh, D. Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders. Arch Gen Psychiatry. 1995;52:296–303.
5.Kendler, KS, Gardner, CO. The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies. Psychol Med. 1997;27:411–419.
6.Kety, SS, Ingraham, LJ. Genetic transmission and improved diagnosis of schizophrenia from pedigrees of adoptees. J Psychiatr Res. 1992;26:247–255.
7.Ingraham, LJ, Kugelmass, S, Frenkel, K, Nathan, M, Mirsky, AF. Twenty-five-year followup of the Israeli High-Risk Study: current and lifetime psychopathology. Schizophr Bull. 1995;21:183–192.
8.DeLisi, LE, Sakuma, M, Tew, W, Kushner, M, Hoff, AL, Grimson, R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74:129–140.
9.Gur, RE, Cowell, P, Turetsky, BIet al.A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55:145–152.
10.Jacobsen, LK, Giedd, JN, Castellanos, FXet al.Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry. 1998;155:678–685.
11.Raz, S, Raz, N. Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging. Psychol Bull. 1990;108:93–108.
12.Lawrie, SM, Abukmeil, SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry. 1998;172:110–120.
13.Degreef, G, Ashtari, M, Bogerts, Bet al.Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Arch Gen Psychiatry. 1992;49:531–537.
14.Bilder, RM, Bogerts, B, Wu, H, Degreef, G, Ashtari, M, Lieberman, J. Independence of morphological markers in schizophrenia. Biol Psychiatry. 1994;35:730.
15.Walker, EF, Levine, RJ. Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am J Psychiatry. 1990;147:1052–1056.
16.Walker, EF, Lewine, RR, Neumann, C. Childhood behavioral characteristics and adult brain morphology in schizophrenia. Schizophr Res. 1996;22:93–101.
17.Weinberger, DR, DeLisi, LE, Neophytides, AN, Wyatt, RJ. Familial aspects of CT scan abnormalities in chronic schizophrenic patients. Psychiatry Res. 1981;4:65–71.
18.Cannon, TD, Mednick, SA, Parnas, J, Schulsinger, F, Praestholm, J, Vestergaard, A. Developmental brain abnormalities in the offspring of schizophrenic mothers, I: contributions of genetic and perinatal factors. Arch Gen Psychiatry. 1993;50:551–564.
19.Cannon, TD, van Erp, TG, Huttunen M et al.Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry. 1998;55:1084–1091.
20.Seidman, LJ, Faraone, SV, Goldstein, JMet al.Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: a pilot magnetic resonance imaging study. Am J Med Genet. 1997;74:507–514.
21.Lawrie, SM, Whalley, H, Kestelman, JNet al.Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet. 1999;353:30–33.
22.Flaum, M, Andreasen, NC. Brain morphology in schizotypal personality as assessed by magnetic resonance imaging. In: Raine, A, Lencz, T, Mednick, SA, eds. Schizotypal Personality. Cambridge: Cambridge University Press; 1995.
23.Buchsbaum, MS, Yang, S, Hazlett, Eet al.Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr Res. 1997;27:45–53.
24.Dickey, CC, McCarley, RW, Voglmaier, MMet al.Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter. Biol Psychiatry. 1999;45:1393–1402.
25.Bilder, RM, Wu, H, Chakos, MHet al.Cerebral morphometry and clozapine treatment in schizophrenia. J Clin Psychiatry. 1994;55 Suppl B:53–56.
26.Woods, BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry. 1998;155:1661–1670.
27.Zipursky, RB, Lim, KO, Sullivan, EV, Brown, BW, Pfefferbaum, A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. ] 1992;49:195–205.
28.Zipursky, RB, Lambe, EK, Kapur, S, Mikulis, DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch Gen Psychiatry. 1998;55:540–546.
29.Harvey, I, Ron, MA, Du Boulay, G, Wicks, D, Lewis, SW, Murray, RM. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol Med. 1993;23:591–604.
30.Schlaepfer, TE, Harris, GJ, Tien, AYet al.Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry. 1994;151:842–848.
31.Lim, KO, Tew, W, Kushner, M, Chow, K, Matsumoto, B, DeLisi, LE. Cortical gray matter volume deficit in patients with first-episode schizophrenia. Am J Psychiatry. 1996;153:1548–1553.
32.Zipursky, RB, Marsh, L, Lim, KOet al.Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biol Psychiatry. 1994;35:501–516.
33.Wolkin, A, Rusinek, H, Vaid, Get al.Structural magnetic resonance image averaging in schizophrenia. Am J Psychiatry. 1998;155:1064–1073.
34.Shenton, ME, Kikinis, R, Jolesz, FAet al.Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. N Engl J Med. 1992;327:604–612.
35.Menon, RR, Barta, PE, Aylward, EHet al.Posterior superior temporal gyrus in schizophrenia: grey matter changes and clinical correlates. Schizophr Res. 1995;16:127–135.
36.Woods, BT, Yurgelun-Todd, D, Goldstein, JM, Seidman, LJ, Tsuang, MT. MRI brain abnormalities in chronic schizophrenia: one process or more? Biol Psychiatry. 1996;40:585–596.
37.Buchanan, RW, Vladar, K, Barta, PE, Pearlson, GD. Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry. 1998;155:1049–1055.
38.Sullivan, EV, Lim, KO, Mathalon, Det al.A profile of cortical gray matter volume deficits characteristic of schizophrenia. Cereb Cortex. 1998;8:117–1124.
39.Lim, KO, Harris, D, Beal, Met al.Gray matter deficits in young onset schizophrenia are independent of age of onset. Biol Psychiatry. 1996;40:4–13.
40.McGlashan, TH, Hoffman, RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry. 2000;57:637–648.
41.Jernigan, TL, Trauner, DA, Hesselink, JR, Tallal, PA. Maturation of human cerebrum observed in vivo during adolescence. Brain. 1991;114:2037–2049.
42.Huttenlocher, PR. Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res. 1979;163:195–205.
43.Giedd, JN, Snell, JW, Lange, Net al.Quantitative magnetic resonance imaging of human brain development: ages 4-18. Cereb Cortex. 1996;6:551–560.
44.Giedd, JN, Blumenthal, J, Jeffries, NOet al.Brain development during childhood and adolescence: a longitudinal MRI study [letter]. Nat Neurosci. 1999;2:861–863.
45.Sowell, ER, Thompson, PM, Holmes, CJ, Batth, R, Jernigan, TL, Toga, AW. Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. Neuroimage. 1999;9:587–597.
46.Selemon, LD, Goldman-Rakic, PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry. 1999;45:17–25.
47.Arnold, SE, Trojanowski, JQ, Gur, RE, Blackwell, P, Han, LY, Choi, C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry. 1998;55:225–232.
48.Keshavan, MS, Stanley, JA, Pettegrew, JW. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part II. Biol Psychiatry. 2000;48:369–380.
49.Stanley, JA, Williamson, PC, Drost, DJet al.An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy [published erratum appears in Arch Gen Psychiatry. 1995 Oct;52(10):799]. Arch Gen Psychiatry. 1995;52:399–406.
50.Shioiri, T, Kato, T, Inubushi, T, Murashita, J, Takahashi, S. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Res. 1994;55:223–235.
51.Deicken, RF, Merrin, EL, Floyd, TC, Weiner, MW. Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia. Schizophr Res. 1995;14:177–181.
52.Keshavan, MS, Anderson, S, Pettegrew, JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res. 1994;28:239–265.
53.Lim, KO, Adalsteinsson, E, Spielman, D, Sullivan, EV, Rosenbloom, MJ, Pfefferbaum, A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry. 1998;55:346–352.
54.Akbarian, S, Bunney, WE Jr., Potkin, SGet al.Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry. 1993;50:169–177.
55.Breier, A, Buchanan, RW, Elkashef, A, Munson, RC, Kirkpatrick, B, Gellad, F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry. 1992;49:921–926.
56.Lim, KO, Hedehus, M, Moseley, M, de Crespigny, A, Sullivan, EV, Pfefferbaum, A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry. 1999;56:367–374.
57.Tien, AY, Eaton, WW, Schlaepfer, TEet al.Exploratory factor analysis of MRI brain structure measures in schizophrenia. Schizophr Res. 1996;19:93–101.
58.Bullmore, ET, Woodruff, PW, Wright, ICet al.Does dysplasia cause anatomical dysconnectivity in schizophrenia? Schizophr Res. 1998;30:127–135.
59.Buchsbaum, MS, Tang, CY, Peled, Set al.MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 1998;9:425–430.
60.Kindermann, SS, Karimi, A, Symonds, L, Brown, GG, Jeste, DV. Review of functional magnetic resonance imaging in schizophrenia. Schizophr Res. 1997;27:143–156.
61.Weinberger, DR, Berman, KF. Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci. 1996;351:1495–1503.
62.Wible, CG, Shenton, ME, Hokama, Het al.Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study. Arch Gen Psychiatry. 1995;52:279–288.
63.Andreasen, NC, Flashman, L, Flaum, Met al.Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA. 1994;272:1763–1769.
64.Andreasen, NC, Ehrhardt, JC, Swayze, VWdet al.Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry. 1990;47:35–44.
65.Raine, A, Sheard, C, Reynolds, GP, Lencz, T. Pre-frontal structural and functional deficits associated with individual differences in schizotypal personality. Schizophr Res. 1992;7:237–247.
66.Raine, A, Lencz, T, Bihrle, S, Ventura, J, Coletti, P. Prefrontal gray matter deficits in schizotypal personality disorder. Schizophr Bull. submitted.
67.Sanfilipo, M, Lafargue, T, Rusinek, Het al.Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry. 2000;57:471–480.
68.Goldstein, JM, Goodman, JM, Seidman, LJet al.Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry. 1999;56:537–547.
69.Crespo-Facorro, B, Kim, J, Andreasen, NC, O'Leary, DS, Magnotta, V. Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study. Biol Psychiatry. 2000;48:110–119.
70.Szeszko, PR, Bilder, RM, Lencz, Tet al.Investigation of frontal lobe subregions in first-episode schizophrenia. Psychiatry Res. 1999;90:1–15.
71.Hege, LM, Kuldau, JM, Zuffante, Pet al.Orbitofrontal cortex in schizophrenia: Measurements of gyrus rectus in MRI. Neuroscience Abstracts. 1997;23:560.
72.Gur, RE, Cowell, PE, Latshaw, Aet al.Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry. 2000;57:761–768.
73.Nelson, MD, Saykin, AJ, Flashman, LA, Riordan, HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry. 1998;55:433–440.
74.Bilder, RM, Bogerts, B, Ashtari, Met al.Anterior hippocampal volume reductions predict “frontal lobe” dysfunction in first episode schizophrenia. Schizophr Ris. 1995;17:47–58.
75.Szeszko, PR, Wu, H, Ashtari, M, Alvir, JMJ, Crandall, DT, Bilder, RM. Left anterior hippocampal volume reductions in schizophrenia. Biol Psychiatry. 1998;43:205.
76.Altshuler, LL, Bartzokis, G, Grieder, T, Curran, J, Mintz, J. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity [letter]. Arch Gen Psychiatry. 1998;55:663–664.
77.Bogerts, B, Ashtari, M, Degreef, G, Alvir, JMJ, Bilder, RM, Lieberman, JA. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res: Neuroimaging. 1990;35:1–13.
78.Bogerts, B, Lieberman, JA, Ashtari, Met al.Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry. 1993;33:236–246.
79.Velakoulis, D, Pantelis, C, McGorry, PDet al.Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry. 1999;56:133–141.
80.Seidman, LJ, Faraone, SV, Goldstein, JMet al.Thalamic and amygdala-hippocampal volume reductions in firstdegree relatives of patients with schizophrenia: an MRI-based morphometric analysis. Biol Psychiatry. 1999;46:941–954.
81.Schreiber, H, Baur-Seack, K, Kornhuber, HHet al.Brain morphology in adolescents at genetic risk for schizophrenia assessed by qualitative and quantitative magnetic resonance imaging [letter]. Schizophr Res. 1999;40:81–4.
82.Callicott, JH, Egan, MF, Bertolino, Aet al.Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype [published erratum appears in Biol Psychiatry. 1999 Jan 15;45(2):following 244]. Biol Psychiatry. 1998;44:941–950.
83.Pantelis, C, Velakoulis, D, Suckling, Jet al.Left medial temporal volume reduction occurs during the transition from high-risk to first-epiode psychosis. Schizophr Res. 1999:35.
84.Hendren, RL, Hodde-Vargas, J, Yeo, RA, Vargas, LA, Brooks, WM, Ford, C. Neuropsychophysiological study of children at risk for schizophrenia: a preliminary report. Journal of the American Academy Child Adolescent Psychiatry. 1995;34:1284–1291.
85.Yeo, RA, Hodde-Vargas, J, Hendren, RLet al.Brain abnormalities in schizophrenia-spectrum children: implications for a neurodevelopmental perspective. Psychiatry Res. 1997;76:1–13.
86.Buchsbaum, MS, Hazlett, EA. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull. 1998;24:343–364.
87.Gur, RE, Maany, V, Mozley, PD, Swanson, C, Bilker, W, Gur, RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry. 1998;155:1711–1717.
88.Dasari, M, Friedman, L, Jesberger, Jet al.A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls. Psychiatry Res. 1999;91:155–162.
89.Hazlett, EA, Buchsbaum, MS, Byne, Wet al.Threedimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Schizophr Bull. 1999;156:1190–1199.
90.Staal, WG, Hulshoff Pol, HE, Schnack, H, van der Schot, AC, Kahn, RS. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am J Psychiatry. 1998;155:1784–1786.
91.Manoach, DS, Gollub, RL, Benson, ESet al.Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry. 2000;48:99–109.
92.Swerdlow, NR, Geyer, MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 1998;24:285–301.
93.Andreasen, NC. The role of the thalamus in schizophrenia. Can J Psychiatry. 1997;42:27–33.
94.Kraepelin, E. Dementia praecox and paraphrenia. Edinburgh: E and S Livingstone; 1919.
95.Pfohl, B, Winokur, G. The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics. Br J Psychiatry. 1982;141:567–572.
96.Fenton, WS, McGlashan, TH. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry. 1994;151:351–356.
97.Wyatt, RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 1991;17:325–351.
98.Loebel, AD, Lieberman, JA, Alvir, JMJ, Mayerhoff, DI, Geisler, SH, Szymanski, SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry. 1992;149:1183–1188.
99.Lieberman, JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry. 1999;46:729–739.
100.Olney, JW, Farber, NB. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology. 1995;13:335–345.
101.Pearlson, GD, Marsh, L. Structural brain imaging in schizophrenia: a selective review. Biol Psychiatry. 1999;46:627–649.
102.Knoll, JLt, Garver, DL, Ramberg, JE, Kingsbury, SJ, Croissant, D, McDermott, B. Heterogeneity of the psychoses: is there a neurodegenerative psychosis? Schizophr Bull. 1998;24:365–379.
103.Nair, TR, Christensen, JD, Kingsbury, SJ, Kumar, NG, Terry, WM, Garver, DL. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res. 1997;74:141–150.
104.Rapoport, JL, Giedd, J, Kumra, Set al.Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry. 1997;54:897–903.
105.Davis, KL, Buchsbaum, MS, Shihabuddin, Let al.Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry. 1998;43:783–793.
106.DeLisi, LE, Tew, W, Xie, Set al.A prospective follow-up study of brain morphology and cognition in firstepisode schizophrenic patients: Preliminary findings. Biol Psychiatry. 1995;38:349–360.
107.Lieberman, JA, Koreen, AR, Chakos, Met al.Factors influencing treatment response and outcome of firstepisode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry. 1996;57:5–9.
108.Zipursky, RB, Zhang-Wong, J, Lambe, EK, Bean, G, Beiser, M. MRI correlates of treatment response in first episode psychosis. Schizophr Res. 1998;30:81–90.
109.Mathalon, DH, Sullivan, EV, Lim, KO, Pfefferbaum, A. Time hospitalized predicts rate of cortical gray matter loss in schizophrenia. Biol Psychiatry. 1998;43:845–855.
110.Bilder, RM, Degreef, G. Morphologic markers of neurodevelopmental paths to schizophrenia. In: Mednick, SA, Cannon, TD, Barr, CE, LaFosse, JM, eds. Developmental Neuropathology of Schizophrenia. NY: Plenum Press; 1991:167–190.
111.Bilder, RM. Structure-function relations in schizophrenia: Brain morphology and neuropsychology. In: Walker, EF, Dworkin, RH, Cornblatt, BA, eds. Progress in Experimental Personality & Psychopathology Research, Vol. 15. NY: Springer Publishing Company; 1992:183–251.
112.Bilder, RM, Szeszko, PR. Structural neuroimaging and neuropsychological impairments. In: Pantelis, C, Nelson, HE, Barnes, TRE, eds. The Neuropsychology of Schizophrenia. NY: John Wiley & Sons; 1996:279–298.
113.Bilder, RM. Neurocognitive impairment in schizophrenia and how it affects treatment options. Can J Psychiatry. 1997;42:255–264.
114.Christensen, BK, Bilder, RM. Dual cytoarchitectonic trends: an evolutionary model of frontal lobe functioning and its application to psychopathology. Can J Psychiatry. 2000;45:247–256.
115.Frith, CD, Friston, K, Liddle, PF, Frackowiak, RS. Willed action and the prefrontal cortex in man: a study with PET. Proc R Soc Lond B Biol Sci. 1991;244:241–246.
116.Frith, C, Dolan, R. The role of the prefrontal cortex in higher cognitive functions. Brain Res Cogn Brain Res. 1996;5:175–181.
117.Frith, CD, Blakemore, S, Wolpert, DM. Explaining the symptoms of schizophrenia: abnormalities in the awareness of action. Brain Res Brain Res Rev. 2000;31:357–363.
118.Pandya, DN, Barnes, CL. Architecture and connections of the frontal lobe. In: Perecman, E, ed. The Frontal Lobes Revisited. NY: IRBN Press; 1987:41–72.
119.Walker, EF. Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr Bull. 1994;20:453–480.
120.Walker, EF, Diforio, D. Schizophrenia: a neural diathesis-stress model. Psychol Rev. 1997;104:667–685.
121.Narr, KL, Thompson, PM, Sharma, Tet al.Three-Dimensional Mapping of Gyral Shape and Cortical Surface Asymmetries in Schizophrenia: Gender Effects. Am J Psychiatry. 2001;158:244–255.
122.Chatterjee, A, Chakos, M, Koreen, Aet al.Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry. 1995;152:1724–1729.
123.Sowell, ER, Thompson, PM, Holmes, CJ, Jernigan, TL, Toga, AW. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions [letter]. Nat Neurosci. 1999;2:859–861.
124.Mandal, MK, Pandey, R, Prasad, AB. Facial expressions of emotions and schizophrenia: a review. Schizophr Bull. 1998;24:399–412.
125.Tucker, DM, Luu, P, Pribram, KH. Social and emotional self-regulation. Ann N Y Acad Sci 1995;769:213–239.
126.Fuster, JM. Synopsis of function and dysfunction of the frontal lobe. Acta Psychiatr Scand Suppl. 1999;395:51–57.
127.Heilman, KM, The neurobiology of emotional experience. J Neuropsychiatry Clin Neurosci. 1997;9:439–448.
128.Thompson, PM, Giedd, JN, Woods, RP, MacDonald, D, Evans, AC, Toga, AW. Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 2000;404:1900–1933.
129.Cyranowski, JM, Frank, E, Young, E, Shear, MK. Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch Gen Psychiatry. 2000;57:21–27.
130.Frith, CD, Done, DJ. Experiences of alien control in schizophrenia reflec a disorder in the central monitoring of action. Psychol Med. 1989;19:359–363.
131.Frith, CD, Friston, KJ, Liddle, PF, Frackowiak, RSJ. Willed action and the prefrontal cortex in man: a study with PET. Proc R Soc Lond B: Biol Sci. 1991;244:241–246.
132.Frith, CD, Done, DJ. Towards a neuropsychology of schizophrenia. Brit J Psychiat. 1998;153:432–443.
133.Paulus, MP, Geyer, MA, Braff, DL. Use of methods from chaos theory to quantify a fundamental dysfunction in the behavioral organization of schizophrenic patients. Am J Psychiatry. 1996;153:714–717.
134.Paulus, MP, Perry, W, Braff, DL. The nonlinear, complex sequential organization of behavior in schizophrenic patients: neurocognitive strategies and clinical correlations. Biol Psychiatry. 1999;46:662–670.
135.Sanides, F. Comparative architectonics of the neocortex of mammals and their evolutionary interpretation. Ann N Y Acad Sci. 1969;167:404–423.
136.Wu, H, Strous, R, Bilder, RM, Alvir, JMJ, Ashtari, M. Shape analysis of hippocampus in schizophrenia. Schizophrenia Res. 1997;24:161.
137.Csernansky, JG, Joshi, S, Wang, Let al.Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci USA. 1998;95:11406–11411.
138.Weinberger, DR, Berman, KF, Suddath, R, Torrey, EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry. 1992;149:890–897.
139.Caine, D, Watson, JD. Neuropsychological and neuropathological sequelae of cerebral anoxia: a critical review. Journal of the International Neuropsychological Society. 2000;6:86–99.
140.Bremner, JD, Randall, P, Scott, TMet al.MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995;152:973–981.
141.Bremner, JD, Randall, P, Vermetten, Eet al.Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report. Biol Psychiatry. 1997;41:23–32.
142.Bremner, JD, Narayan, M, Anderson, ER, Staib, LH, Miller, HL, Charney, DS. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000;157:115–118.
143.McNeil, TF, Cantor-Graae, E, Weinberger, DR. Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiatry. 2000;157:203–212.
144.Dickey, CC, McCarley, RW, Voglmaier, MMet al.Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter. Biol Psychiatry. 1999;45:1393–1402.
145.Meehl, PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol. 1962;17:827–838.
146.Meehl, PE. Schizotaxia revisited. Arch Gen Psychiatry. 1989;46:935–944.
147.Cornblatt, BA. Predictors of schizophrenia and preventive intervention. In: Breier, A, Tran, P.V., Bymaster, A, Tollefson, C, eds. Current Issues in the Psychopharmacology of Schizophrenia. Baltimore, MD: Williams & Wilkins; 2000.
148.Yung, AR, McGorry, PD. The prodromal phase of firstepisode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353–370.